Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones12-09

DJ Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. $(TECH)$ slid 2.25% to $60.29 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.35% to 6,846.51 and Dow Jones Industrial Average falling 0.45% to 47,739.32.

This was the stock's third consecutive day of losses.

Bio-Techne Corp. closed 23.95% below its 52-week high of $79.28, which the company reached on February 5th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ fell 2.63% to $321.23, Charles River Laboratories International Inc. $(CRL)$ rose 1.52% to $187.12, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.19% to $53.30.

Trading volume (2.1 M) remained 78,860 below its 50-day average volume of 2.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 08, 2025 17:18 ET (22:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590036919?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-09 06:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590036919","market":"fut","top_or_hot":-1,"title":"Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Bio-Techne Corp. <a href=\"https://laohu8.com/S/TECH\">$(TECH)$</a> slid 2.25% to $60.29 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index  falling 0.35% to 6,846.51 and Dow Jones Industrial Average  falling 0.45% to 47,739.32. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Bio-Techne Corp. closed 23.95% below its 52-week high of $79.28, which the company reached on February 5th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> fell 2.63% to $321.23, Charles River Laboratories International Inc. <a href=\"https://laohu8.com/S/CRL\">$(CRL)$</a> rose 1.52% to $187.12, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> fell 0.19% to $53.30. \n</p>\n<p>\n     Trading volume (2.1 M) remained 78,860 below its 50-day average volume of 2.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 17:18 ET (22:18 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-09 06:18</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Bio-Techne Corp. <a href=\"https://laohu8.com/S/TECH\">$(TECH)$</a> slid 2.25% to $60.29 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index  falling 0.35% to 6,846.51 and Dow Jones Industrial Average  falling 0.45% to 47,739.32. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Bio-Techne Corp. closed 23.95% below its 52-week high of $79.28, which the company reached on February 5th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> fell 2.63% to $321.23, Charles River Laboratories International Inc. <a href=\"https://laohu8.com/S/CRL\">$(CRL)$</a> rose 1.52% to $187.12, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> fell 0.19% to $53.30. \n</p>\n<p>\n     Trading volume (2.1 M) remained 78,860 below its 50-day average volume of 2.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 17:18 ET (22:18 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TECH","symbol_name":"Techne Corporation","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2590036919","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590036919","pubTimestamp":1765232280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bio-Techne Corp.  slid 2.25% to $60.29 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.35% to 6,846.51 and Dow Jones Industrial Average  falling 0.45% to 47,739.32.This was the stock's third consecutive day of losses.Bio-Techne Corp. closed 23.95% below its 52-week high of $79.28, which the company reached on February 5th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc.  fell 2.63% to $321.23, Charles River Laboratories International Inc.  rose 1.52% to $187.12, and BioMarin Pharmaceutical Inc.  fell 0.19% to $53.30.Trading volume  remained 78,860 below its 50-day average volume of 2.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"TECH":"Techne Corporation"},"translate_title":"尽管当天下跌，Bio-Techne Corp.股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TECH":1.5},"content_text":"DJ Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Bio-Techne Corp. $(TECH)$ slid 2.25% to $60.29 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.35% to 6,846.51 and Dow Jones Industrial Average  falling 0.45% to 47,739.32. \n\n\n     This was the stock's third consecutive day of losses. \n\n\n     Bio-Techne Corp. closed 23.95% below its 52-week high of $79.28, which the company reached on February 5th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ fell 2.63% to $321.23, Charles River Laboratories International Inc. $(CRL)$ rose 1.52% to $187.12, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.19% to $53.30. \n\n\n     Trading volume (2.1 M) remained 78,860 below its 50-day average volume of 2.1 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 17:18 ET (22:18 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590036919","isCrawlerRequest":true}